20,831
Total Claims
$4.8M
Drug Cost
2,231
Beneficiaries
$2,134
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+40%
Cost per patient vs peers
$2,134 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 18,394 claims · $531K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Macitentan | 73 | $948K |
| Apixaban | 690 | $818K |
| Selexipag | 29 | $600K |
| Sacubitril/Valsartan | 377 | $500K |
| Riociguat | 32 | $458K |
| Dapagliflozin Propanediol | 145 | $188K |
| Rivaroxaban | 136 | $166K |
| Empagliflozin | 127 | $163K |
| Evolocumab | 195 | $152K |
| Ticagrelor | 78 | $64K |
| Ranolazine | 367 | $64K |
| Alirocumab | 78 | $56K |
| Isosorbide Mononitrate | 1,618 | $41K |
| Azilsartan Med/Chlorthalidone | 76 | $31K |
| Atorvastatin Calcium | 1,738 | $30K |
Prescribing Profile
80
Unique Drugs
$1.8M
Patient Profile
71
Avg Age
62%
Female
2.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data